Blog

Comply With the New EMA CT-C19 Remote Source Data Verification (rSDV) Guidance

Feb 25, 2021 12:53:23 PM //

0 Comments

Read More

Agile Lunexis™ ePRO+ Methodology: Eliminating Barriers to Cancer Research

Jan 25, 2021 10:21:18 AM // posted in eCOA/ePRO

0 Comments

Read More

Sponsor and CRO’s Choice: Holistic On-Site, At-Home, and Virtual eSource Flexibility for Clinical Trials

Dec 18, 2020 5:40:45 PM //

0 Comments

Read More

A Unified Experience in eSource Patient Data Capture and Integration for Sites and Sponsors

Dec 2, 2020 12:06:50 PM //

0 Comments

Read More

Mixed-Modality Deployment Compatible With Any Trial Design

Dec 2, 2020 12:06:37 PM //

0 Comments

Read More

One Patient Data Capture Application That’s Everything to Everyone: The Evolution of Lunexis™ ePRO+

Dec 2, 2020 12:06:24 PM //

0 Comments

Read More

Making Data Central to Your CNS and Pain Trials: A Therapeutic-Area-Specific Approach to Data Capture Solutions

Sep 28, 2020 3:46:40 PM //

0 Comments

Read More

DDC vs. EDC: Frequently Asked Questions

Aug 6, 2020 10:07:23 AM //

0 Comments

Read More

Handling Complexity in GI Trials ⁠— a Purpose-Built eCOA/ePRO Solution: The GI Library

Jun 11, 2020 11:55:23 AM //

0 Comments

Read More

Lupus Studies Deserve a Better Approach

May 14, 2020 8:03:02 AM // posted in Lupus

0 Comments

Read More
All posts

Subscribe to Email Updates

Categories

Recent Posts

About Clinical Ink

Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Our Lumenis eSource clinical technology and configurable direct data capture, eCOA, ePRO, and eConsent modules — a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source — naturally enhance your clinical trial workflow by reducing manual labor, providing anytime, anywhere data access, and saving resources as your trials progress. Visit clinicalink.com.